Finance

Lists
001060:KRX
JW Pharmaceutical Corp
â‚©27,400.00
+1.48%
(+400.00) 1D
Aug 28, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001060...
Open
â‚©26,900
High
â‚©27,550
Low
â‚©26,450
Mkt. cap
655.75B
Avg. vol.
61.46K
Volume
66.26K
Dividend
2.37%
Quarterly dividend
â‚©162
Ex-dividend date
Dec 27, 2024
P/E ratio
9.25
52-wk high
â‚©39,250
52-wk low
â‚©20,700
EPS
â‚©2,962
Shares outstanding
23.29M
No. of employees
1K
Open
â‚©26,900
High
â‚©27,550
Low
â‚©26,450
Mkt. cap
655.75B
Avg. vol.
61.46K
Volume
66.26K
Dividend
2.37%
Quarterly dividend
â‚©162
Ex-dividend date
Dec 27, 2024
P/E ratio
9.25
52-wk high
â‚©39,250
52-wk low
â‚©20,700
EPS
â‚©2,962
Shares outstanding
23.29M
No. of employees
1K
About JW Pharmaceutical Corp
CEOLee, Kyung Ha
Employees1.07K
Founded1945
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
200.02B
198.94B
199.88B
222.02B
Cost of goods sold
105.39B
109.09B
101.43B
116.73B
Cost of revenue
105.39B
109.09B
101.43B
116.73B
Research and development expenses
7.33B
15.27B
9.38B
11.86B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55.58B
60.42B
55.91B
59.90B
Operating expense
62.60B
80.98B
64.88B
71.95B
Total operating expenses
167.99B
190.07B
166.31B
188.68B
Operating income
32.03B
8.87B
33.58B
33.34B
Other non operating income
-4.64B
8.03B
1.21B
835.27M
EBT including unusual items
27.85B
17.49B
35.20B
34.76B
EBT excluding unusual items
27.85B
15.96B
35.20B
34.76B
Income tax expense
-2.74B
2.18B
7.72B
6.86B
Effective tax rate
-9.83%
12.44%
21.93%
19.75%
Other operating expenses
-
-
-
-
Net income
30.59B
15.32B
27.48B
27.89B
Net profit margin
15.29%
7.70%
13.75%
12.56%
Earnings per share
1.27K
-
-
-
Interest and investment income
-
3.34B
-
-
Interest expense
-
-4.42B
-
-
Net interest expenses
-
-1.09B
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
36.72B
13.65B
38.56B
38.37B
Gain or loss from assets sale
5.12M
3.00K
-10.00M
3.00K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps